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Introduction
Cell migration plays a central role in physiological processes as embryogenesis, wound healing or immunity, whereas aberrant cell motility underlies pathological conditions such as inflammation or cancer progression [1, 2] . Chemotaxis integrates complex steps coordinated by transiently activated signalling networks, leading to cell polarization, membrane protrusion and generation of dynamic adhesion and traction forces [3, 4, 5].
Many G protein-coupled receptors (GPCR), such as those for chemokines, are involved in gradient sensing and cell migration [5, 6] . Upon stimulation, GPCR initiate G protein-dependent signalling pathways and also become phosphorylated by serine/threonine kinases termed G protein-coupled receptor kinases (GRKs), of which GRK2 is the most ubiquitous and well-characterized [7, 8] . This event promotes the association of arrestins, leading to GPCR desensitization and internalization. GRKs are emerging as complex regulators of cell migration processes, since their involvement in cell motility not only relies in their canonical role as "negative" modulators of GPCR signalling, but also involves novel substrates and interacting partners [8] [9] [10] [11] .
We discuss herein recent evidence linking GRKs (particularly GRK2) to the different functional facets of cell migration, how such diverse roles might be orchestrated in response to stimuli, and the implications of these findings in physiopathological contexts.
The conundrum of GRK2 in migration: how does GRK2 actually modulate the chemotactic response?
Numerous reports have ascribed the effects of GRK2 on chemotaxis to its ability to trigger desensitization of particular chemokine receptors, thus controlling the intensity and duration of agonist stimulation [6, 7, 12] . Down-modulation of GRK2 levels increases chemotactic responses to different agonists in immune cell types, whereas its enhanced expression attenuates chemotaxis, consistent with its canonical negative role in GPCR signalling (Table 1) .
However, the overall impact of GRK2 levels on cell migration is not straightforward and varies dependent on the stimuli and/or cell type considered [ Table   1 , refs. 8-11]. GRK2 down-modulation can lead to decreased migration of immune cell types towards certain stimuli [13] , and this kinase plays a positive role in epithelial cell migration [14] .
These heterogeneous results raise questions about the functional role of GPCR desensitization during directed migration, and suggests that the global effect of GRK2 on chemotaxis would depend on the integrated modulation of different steps of the chemotactic process (receptor sensing, cell polarization, membrane protrusion, adhesion/de-adhesion cycles) in given cell types and in response to specific stimuli.
GRK2 in gradient sensing: a role for receptor phosphorylation?
Directional sensing involves the conversion of graded receptor activation by chemoattractants into a sharp asymmetry of key downstream signalling components.
PI3K and PTEN (besides other redundant pathways), are redistributed towards and away the gradient, respectively, allowing for local accumulation of PI(3,4,5)P 3 ,, what serves to specify pseudopodia formation and to guide cell movement [15, 16] .
This response is extremely sensitive and localized PI(3,4,5)P 3 production depends only on the gradient steepness [15, 16] . In steep gradients, cells generate a single, well-defined pseudopodium and move straight towards the signal source.
Conversely, in shallow gradients, chemotaxis is mediated by biased choices between randomly projected pseudopodia, resulting in a tortuous and time-consuming tracking [3, 5, 16] . In steep gradients, high local fraction of receptor occupancy versus lower global occupancy would favour the generation of internal asymmetry [15] . In this context, it is tempting to suggest that GRK2-triggered receptor desensitization/internalization might influence how receptors sense the strength and steepness of chemotactic gradients (less GRK2, steeper, more GRK2, weaker gradients, see detailed model in Figure 1 ).
Consistently, GRK2 levels are important for defining the stop signal of neutrophil migration [17] . These cells adopt a random walk and cease directed locomotion when exposed to saturating concentrations of fMLP, which triggers receptor desensitization/internalization in a GRK2-dependent manner. Therefore, upon GRK2 silencing cessation of migration is not achieved properly, resulting in sustained motility.
Interestingly, dependence on steeper chemotactic gradients diminishes in polarized cells. Therefore, GRK2-mediated receptor phosphorylation/desensitization may become more relevant in immune cells, in contrast to intrinsically polarized epithelial cells and fibroblasts, leading to striking differences in how GRK2 impacts migration [9, 11, 14] . Receptor desensitization also might be more critical when cells migrate between opposed chemoattractant gradients. Notably, GRK2-mediated desensitization of S1P1 receptors allows T cells to "ignore" high vascular S1P
concentrations in order to follow lymph node guiding cues [13, 18] .
GRK2 in cell polarization and membrane protrusion: shaping cells for motion
Cell polarization and the formation of a leading edge is a key step in chemotaxis.
GRKs can also regulate these processes by modulating novel substrates and effectors Interestingly, GRK2 can serve as a RhoA-activated scaffold protein for MAPK activation in response to EGF stimulation [30] . In a motile cell, GRK2/RhoA interaction would be expected to occur predominantly at the rear edge, wherein RhoA activation peaks, and localized MAPK could increase FA turnover.
Besides, GRK2 might influence the disassembly of FAs by means of the control of tubulin deacetylation. Targeting of FAs by dynamic MTs exerts a negative influence on focal adhesion maintenance [27] . Upon GRK2 downregulation, hyper-acetylated
MTs would be less efficient in disassembling FAs, enhancing cell spreading and impairing motility [11, 24] .
Role of GRKs other than GRK2 in cell migration
Other GRKs have been reported to modulate cell migration, although information about the molecular mechanisms involved is scarce. Comparison of GRKs knockout mice in an acute inflammatory arthritis model indicated a role for GRK2, GRK3 and GRK6, but not GRK5, in granulocyte migration in such conditions [31, 32] .
Interestingly, lymphocytes from beta-arrestin-2 and GRK6-deficient animals displayed defective chemotaxis towards CXCL12, suggesting a positive role in cell motility in such context [33] .
GRK5 attenuates atherosclerosis by desensitizing CCR2 in monocytes and inhibiting their migration [34] . In epithelial cells, a functional screening identified GRK6 as a critical mediator in integrin-mediated cell adhesion and migration of tumor cells [35] , and GRK6 deficiency reportedly promotes CXCR2 receptor-mediated tumor progression and metastasis in a lung carcinoma model [36] . It would be interesting to investigate whether the modulation of cell migration by these GRKs is mostly related to their canonical role as specific or more active regulators of given GPCRs in different cell types or novel substrates and interactors as those identified for GRK2 are also targeted.
Physiological and pathological implications
Altered activity/expression of GRKs might critically contribute to deregulate cell motility in development or wound healing or in pathological situations related to inflammation or tumor progression [7, 8, 11, 12] . Several GRK2-interacting signalling modules play well-known roles in invasive motility, including integrins, GPCRs (such as S1P, chemokine or PAR receptors), the EGFR family, RhoA, Rac1, or ERMs [37] [38] [39] . Increased GRK2 levels could strengthen features of tumor cell motility by increasing integrin and S1P-mediated signaling, which are amplified in breast cancer patients and are critical for invasive migration in 3D-collagen matrices [39] [40] . In addition, GRK2 could also collaborate with HDAC6 in promoting cytoskeletal and adhesion dynamics required for tumoural migration and invasion, as well as in HDAC6- Activation of the Toll-like receptor (TLR)-4 pathway promotes GRK2 and GRK5
transcriptional down-regulation, leading to decreased chemokine receptor desensitization and increased migration of polymorphonuclear leukocytes [44] .
Interestingly, several reports have related the inability of neutrophils from severe sepsis patients to migrate towards CXCL2 or CXCL8 chemoattractants, and thus to promote bacterial clearance, to increased levels of GRK2 and GRK5 [31] . Notably, sepsis attenuation by Interleukin-33 may involve down-modulation of GRK2 expression in neutrophils, leading to enhanced CXCR2 signaling and neutrophil chemotaxis [45] .
Higher up-regulation of GRK2 in diabetic mice exacerbated CXCR2 downregulation and reduction of neutrophil migration in sepsis [46] . High GRK2 expression in neutrophils from malaria patients suggests a possible mechanism for an enhanced susceptibility to secondary bacterial infection during malaria [47] .
Overall, these data encourage future studies to investigate the role of changes in the expression/functionality of GRKs in the triggering or development of physiopathological processes related to cell motility.
Perspectives and conclusions
GRKs appear as physiologically relevant integrative nodes in cell migration,.
Given the distinct signalling and cytoskeleton modules related to chemotaxis potentially modulated by GRKs, one key issue is to understand how are orchestrated in response to specific stimuli in distinct cell types. Moreover, an adequate combination of in vitro and in vivo experimental approaches is needed to fully decipher the functional role of GRKs in motility.
GRK2 phosphorylation by other kinases is emerging as a key "signaling switch"
governing substrate specificity and interaction with cellular partners during cell migration (Figure 3 ). Tyrosine-phosphorylation of GRK2 in response to chemotactic signals enhances interaction with GIT1, whereas S670 phosphorylation by MAPK displays an opposite effect [14] . In turn, dynamic S670 GRK2 phosphorylation specifically allows GRK2 to phosphorylate HDAC6 and thus trigger transient local tubulin de-acetylation [26] . Notably, S670 GRK2 phosphorylation by ERK or p38
Mapk inhibits its interaction with G and prevents GPCR desensitization. [7, 8, 48] .
Alternatively, phosphorylation of the FPR1 receptor by p38MAPK has been reported to prevent GRK2 recruitment and so facilitate neutrophil migration [17] . Therefore, the subcellular localization and phosphorylation status of GRK2 would be a key factor underlying the dynamic and stimuli-specific switching of partners relevant to cell migration, allowing the sequential and coordinated participation of GRKs in several steps of the cell motility process [10,11].
Lessons and potential bias from experimental models should also be considered. Most studies about GRKs in migration are based in in vitro systems (2D-random motility, wound healing and transwell assays), and may therefore need further analysis.
Transwell assays mainly assess cell polarization and persistence, overlooking the influence of the structural architecture/biophysical properties of the extracellular matrix. 
